These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 4611539)

  • 1. Immobilization of enzymes, adsorbents, or both within semipermeable microcapsules (artificial cells) for clinical and experimental treatment of metabolite-related disorders.
    Chang TM
    Birth Defects Orig Artic Ser; 1973 Mar; 9(2):66-76. PubMed ID: 4611539
    [No Abstract]   [Full Text] [Related]  

  • 2. 51 Cr-L-asparagine accumulation by tumors: the influence of L-asparaginase treatment.
    Anghileri LJ
    J Nucl Biol Med; 1970; 14(4):150-2. PubMed ID: 5538035
    [No Abstract]   [Full Text] [Related]  

  • 3. Development of urease-chitosan membrane.
    Krajewska B; Leszko M; Zaborska W
    Polim Med; 1990; 20(1-4):31-41. PubMed ID: 2129516
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The in vivo effects of semipermeable microcapsules containing L-asparaginase on 6C3HED lymphosarcoma.
    Chang TM
    Nature; 1971 Jan; 229(5280):117-8. PubMed ID: 4923094
    [No Abstract]   [Full Text] [Related]  

  • 5. The development and first clinical use of semipermeable microcapsules (artificial cells) as a compact artificial kidney.
    Chang TM; Malave N
    Trans Am Soc Artif Intern Organs; 1970; 16():141-8. PubMed ID: 5454159
    [No Abstract]   [Full Text] [Related]  

  • 6. Uptake of asparagine C-14 into the pyrimidine synthesis pathway of guinea pig serum sensitive 6C3HED lymphosarcoma cells.
    Woods JS; Dixon RL
    Proc West Pharmacol Soc; 1968; 11():67-8. PubMed ID: 5757098
    [No Abstract]   [Full Text] [Related]  

  • 7. [Use of immobilized enzymes in detoxification. II. Immobilization and characterization of enzymes on hollow fiber devices].
    Mazzola G; Cremonesi P; Colombi S; Vecchio G; Agnellini D; Pietta PG
    Minerva Nefrol; 1979; 26(2):185-7. PubMed ID: 471347
    [No Abstract]   [Full Text] [Related]  

  • 8. Methods for the therapeutic applications of immobilized enzymes.
    Chang TM
    Methods Enzymol; 1976; 44():676-98. PubMed ID: 1021699
    [No Abstract]   [Full Text] [Related]  

  • 9. Inhibition of thymidine and basic amino acid metabolism in P1798 lymphosarcoma by L-asparaginase.
    Mashburn LT; Landin LM
    Cancer Res; 1974 Feb; 34(2):313-8. PubMed ID: 4589953
    [No Abstract]   [Full Text] [Related]  

  • 10. The effects of L-asparaginase on the amino acid incorporation of mouse lymphoid tumors.
    Mashburn LT; Gordon CS
    Cancer Res; 1968 May; 28(5):961-7. PubMed ID: 5652310
    [No Abstract]   [Full Text] [Related]  

  • 11. Biodegradable semipermeable microcapsules containing enzymes, hormones, vaccines, and other biologicals.
    Chang TM
    J Bioeng; 1976 Nov; 1(1):25-32. PubMed ID: 1052520
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biomedical applications of artificial cells.
    Chang TM
    Biomed Eng; 1973 Aug; 8(8):334-9. PubMed ID: 4750773
    [No Abstract]   [Full Text] [Related]  

  • 13. In vivo effects of intraperitoneally injected L-asparaginase solution and L-asparaginase immobilized within semipermeable nylon microcapsules with emphasis on blood L-asparaginase, 'body' L-asparaginase, and plasma L-asparagine levels.
    Siu Chong ED; Chang TM
    Enzyme; 1974; 18(3):218-39. PubMed ID: 4601662
    [No Abstract]   [Full Text] [Related]  

  • 14. Semipermeable aqueous microcapsules ("artificial cells"): with emphasis on experiments in an extracorporeal shunt system.
    Chang TM
    Trans Am Soc Artif Intern Organs; 1966; 12():13-9. PubMed ID: 5960694
    [No Abstract]   [Full Text] [Related]  

  • 15. Semipermeable microcapsules containing catalase for enzyme replacement in acatalasaemic mice.
    Chang TM; Poznansky MJ
    Nature; 1968 Apr; 218(5138):243-5. PubMed ID: 5648221
    [No Abstract]   [Full Text] [Related]  

  • 16. Inhibition of lymphoma 6C3HED by L-asparaginase from Serratia marcescens.
    Boyd JW; Phillips AW
    J Natl Cancer Inst; 1971 Jun; 46(6):1271-6. PubMed ID: 4932428
    [No Abstract]   [Full Text] [Related]  

  • 17. [Metabolism of amino acids and urea cycle: animal models of enzymopathies].
    Kamoun PP
    Ann Biol Clin (Paris); 1992; 50(2):63-70. PubMed ID: 1443794
    [TBL] [Abstract][Full Text] [Related]  

  • 18. L-Asparaginase: discovery and development as a tumor-inhibitory agent.
    Broome JD
    Cancer Treat Rep; 1981; 65 Suppl 4():111-4. PubMed ID: 7049374
    [No Abstract]   [Full Text] [Related]  

  • 19. Asparagine incorporation into the DNA of hepatic and 6C3HED murine lymphosarcoma cells.
    Woods JS; Lee IP; Dixon RL
    Cancer Res; 1970 Apr; 30(4):1210-1. PubMed ID: 5537321
    [No Abstract]   [Full Text] [Related]  

  • 20. On the clinical use of microencapsulated zirconium phosphate-urease for the treatment of chronic uremia.
    Kjellstrand C; Borges H; Pru C; Gardner D; Fink D
    Trans Am Soc Artif Intern Organs; 1981; 27():24-30. PubMed ID: 7036498
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.